Updated:
Auven Therapeutics
Auven Therapeutics is a private equity manager based in St. Thomas, US Virgin Islands.
Auven Therapeutics
Auven Therapeutics, formerly Celtic Therapeutics, is a private equity firm. It utilizes a fund structure and an internal drug development company to manage drug development and grow therapeutic assets. The firm addresses a market opportunity by investing in small biotechnology companies and providing late-stage clinical products to established pharmaceutical companies.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
St. Thomas
Corporate office
St. Thomas, US Virgin Islands
Frequently asked questions
What is Auven Therapeutics?
Auven Therapeutics is a private equity headquartered in St. Thomas, United States.
Where is Auven Therapeutics headquartered?
Auven Therapeutics is headquartered in St. Thomas, United States, in the North America region.
What is Auven Therapeutics's assets under management?
Auven Therapeutics reports approximately Undisclosed in assets under management, as tracked by Altss.
What does Altss track for Auven Therapeutics?
Altss maintains an OSINT-verified profile of Auven Therapeutics covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is Auven Therapeutics's website?
Auven Therapeutics's public website is www.auventx.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is Auven Therapeutics?
Auven Therapeutics is classified by Altss as a Private Equity, operating from United States within the North America region.
How does Altss source intelligence on Auven Therapeutics?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Auven Therapeutics's Altss profile last updated?
Auven Therapeutics's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: